Grants
|
Deciphering peripheral immune signatures in Multiple System Atrophy: a multicentre single-cell approach (ImmuMSA). Carles Colomer Prize for Multiple System Atrophy Research, Pasqual Maragall Foundation |
|
2027-2032 |
|
300.000 € |
|
Developing a multiple system atrophy pain scale, European Reference Network for Rare Neurological Disorders |
|
2025-2026 |
|
39.941 € |
|
Mission MSA Center of Excellence |
|
2025-2026 |
|
10.000 $ |
|
Unravelling the pathogenic role of iron dysregulation in MSA, FWF, Grant-DOI 10.55776/PAT4208323 |
|
2025-2028 |
|
347.302 € |
|
Selective oral NLRP3 inhibitor, to mitigate the disease progression of PD: building pre-clinical evidence towards a clinical trial, MJFF-022681 |
|
2023-2024 |
|
387.206 $ |
|
Transcriptomic profiling of MSA-like disease progression: a potential strategy to identify novel therapeutic targets, TWF |
|
2023 |
|
39.000 € |
|
Translational Research in NeuroDegeneration (TReND), MUIDK-2022-1-1 |
|
2023-2027 |
|
1.377.241 € |
|
Medical Decision Making in Multiple System Atrophy, FWF FG 2700 |
|
2023-2028 |
|
1.499.221 € |
|
Pain in multiple system atrophy, US MSA Coalition |
|
2022-2024 |
|
92.331 € |
|
The pathogenesis of MSA, Private donation |
|
2022 |
|
100.000 € |
|
Track MSA, NIH |
|
2022 |
|
225.000 $ |
|
Iron dyshomeostasis in MSA, MUI-START |
|
2022-2023 |
|
40.000 € |
|
Clinical trial readiness for MSA, NIH |
|
2022-2026 |
|
578.224 $ |
|
Abdominal binders for orthostatic hypotension in MSA, Dr. Johannes and Hertha Tuba Research Funding |
|
2021 |
|
100.000 € |
|
Physiotherapy RCT in MSA-P, FWF DACH Project, I 4795 |
|
2020 |
|
1.156.000€ |
|
Abdominal binders for orthostatic hypotension in MSA: a RCT, MSA Coalition |
|
2020 |
|
50.000 $ |
|
MSA Revision Taskforce, MDS |
|
2019-2021 |
|
35.000 $ |
|
Differences in sudomotor dysfunction in neuromyelitis optica spectrum disorder and multiple sclerosis, ÖAD |
|
2020 |
|
7.883 € |
|
The lion’s tail family – clinical characterization and genetic analysis of a Bavarian multiplex pedigree with autosomal dominant Parkinsonism, Austrian Parkinson Fund |
|
2019 |
|
49.444 € |
|
Fit for Science, Land Tyrol |
|
2019 |
|
47.000 € |
|
Global MSA Registry & Natural History Study, MSA Coalition |
|
2017-2018 |
|
50.000 $ |
|
Targeting alpha-synuclein pathology with the molecular tweezer CLR01 in MSA: optimization of drug delivery and biochemical analysis, MSA Coalition |
|
2017-2018 |
|
50.000 $ |
|
Inside the gait – a new era on the horizon for atypical parkinsonian disorders, MSA Coalition |
|
2017-2018 |
|
50.000 $ |
|
ASAP Tau, JPND Research |
|
2016-2017 |
|
49.900 € |
|
ARTEMIS: Targeting alpha-synuclein for treating MSA, E-Rare, FWF I2102 |
|
2016-2018 |
|
308.500 € |
|
Defining diagnostic brain MRI markers in early MSA with a novel toolbox: the MINY* study, MSA Coalition |
|
2015 |
|
46.500 € |
|
Targeting α-synuclein pathology with the molecular tweezer CLR01 in MSA, MSA Coalition |
|
2015 |
|
46.500 € |
|
Alpha-synuclein: a pathogenic trigger and interventional target in MSA. FWF SFB F4414 |
|
2015-2019 |
|
479.955 € |
|
Progression of microglial activation in a mouse model of MSA. FWF SPIN DK W1206-08 |
|
2014-2017 |
|
150.000 € |
|
The role of autophagy inhibition in oligodendroglial cytoplasmic inclusion formation in multiple system atrophy, TWF UNI-0404/1660 |
|
2015 |
|
23.455 € |
|
Cardiovascular phenotyping of a transgenic mouse model of multiple system atrophy, MUI-Start 2014-05-005 |
|
2014-2015 |
|
15.071 € |
|
Unrestricted MSA Research Grant, Private Donation |
|
2014 |
|
10.000 € |
|
MultiSyn: Multimodal Imaging of rare Synucleinopathies, HEALTH-F5-2013-602646 |
|
ab 2013 |
|
537.410 € |
|
Autonomic dysfunction in MSA, Parkinsons & Movement Disorder Foundation |
|
2013 |
|
10.000 $ |
|
Cardiac Magnetic Resonance Spectroscopic Correlates of Cardiac Sympathetic Denervation in Parkinson’s disease: A Comparison with MSA-P and Healthy Controls, KLI380 |
|
ab 2013 |
|
109.620 € |
|
Alpha-Synuclein and Oligodendroglia in MSA Pathogenesis, FWF P25161 |
|
ab 2012 |
|
302.773 € |
|
Functional read-outs and novel interventional targets in a transgenic MSA model, FWF SFB F44 |
|
ab 2011 |
|
364.790 € |
|
Krankheitsverlauf und Prognose der Multisystematrophie, ÖNB 13946 |
|
2010-2011 |
|
28.000 € |
|
Effekte der Neurotransplantation in einem optimierten Modell der MSA, TWF Projekt, GZ 29487 |
|
2011-2012 |
|
16.600 € |
|
Cell Fate Analysis of Embryonal and Adult Stem Cell-Derived Grafts in PD and MSA Models, IFTZ Projekt |
|
2008-2010 |
|
100.800 € |
|
The role of dopaminergic stimulation on striatal graft survival and function in the MSA rat model, MFI Projekt 9441 |
|
2008 |
|
65.000 € |
|
MSA and Neuroinflammation, FWF Projekt P19989-B05 |
|
2007-2010 |
|
241.752 € |
|
Brain Repair in MSA, FWF Projekt DK-C34-B05 |
|
2007-2010 |
|
135.000 € |
|
MSA Konsensuskriterien, NIH Projekt |
|
2007 |
|
35.000 € |
|
Autonomic failure in a MSA mouse model, TWF Projekt |
|
2007 |
|
4.000 € |
|
MSA Neurotransplantation, FWF Projekt P17905-B05 |
|
2005-2008 |
|
216.772 € |
|
Verhaltensphysiologie der L-Dopa Response im MSA-SND Modell, MFF Projekt |
|
2005-2006 |
|
9.780 € |
|
Diagnostische Wertigkeit der MIBG Herz-Szintigraphie im Vergleich zu diffusionsgewichtetem MRT und cardiovaskulären autonomen Funktionstests in der Differenzialdiagnose von Parkinson-Syndromen, ONB Projekt 10982 |
|
2004 |
|
28.000 € |
|
The role of alpha-synuclein in glial cells, FWF Projekt P16128-B01 |
|
2003-2006 |
|
189.992 € |
|
Neuroprotektion im Rattenmodell der MSA, FWF Projekt P14633-PHA |
|
2002-2004 |
|
150.070 € |
|
European MSA Study Group, EU Projekt QLRT-2000-00661 |
|
2000-2005 |
|
543.363 € |
|
Progression der striatonigralen Degeneration bei der MSA, Forschungsauftrag des BMWV 70038/2-Pr4/98 |
|
1999-2003 |
|
170.420 € |
|
Experimental neuroregeneration and protection in an animal model of MSA, ONB Projekt 8298 |
|
1999-2000 |
|
43.240 € |
|
Parkinson-Tiermodelle, Forschungsstipendium der osterreichischen Parkinson-Gesellschaft |
|
1997-1998 |
|
5.090 € |
|
Clinical investigations of nicotine in Parkinson`s disease, VERUM-Stiftung, BRD |
|
1995-1996 |
|
45.780 € |
|
Neurotransplantationsmodell der MSA, FWF Projekt P11748 MED |
|
1994-1997 |
|
142.440 € |
|
Dreijähriges Forschungsstipendium der englischen Parkinson Gesellschaft, London |
|
1992-1994 |
|
119.550 € |